Lizée D, Cornu J-N, Peyrat L, Ciofu C, Beley S, Haab F
Service d'urologie, université Paris VI, hôpital Tenon, groupe hospitalo-universitaire Paris-Est, Assistance publique-Hôpitaux de Paris (AP-HP), 4, rue de la Chine, 75970 Paris cedex 20, France.
Prog Urol. 2013 Sep;23(11):917-25. doi: 10.1016/j.purol.2013.07.008. Epub 2013 Aug 2.
To conduct a review about the use of single incision mini-slings (SIMS) to manage non-neurogenic stress urinary incontinence in women.
Literature search in Pubmed/MEdline database until june 2013. TVT-Secur™ was excluded because this device is not anymore marketed.
Ajust™ and Mini-Arc™ were the two main SIMS evaluated in the literature. Studies about Mini-Arc™ generated heterogeneous results, with a success rate between 44% and 91% after 1 year. Ajust™ was the most promising device with 80% efficacy after mid-term follow-up. All evaluated SIMS had a low rate of immediate complications. Two randomized controlled trials comparing SIMS and traditional mid-urethral slings were identified, as well as one meta-analysis; they all concluded to non-superiority or inferiority for the mini-sling versus traditional slings.
Due to short follow-up, limited evidence and heterogeneous data, SIMS are not yet standard of care and further research is warranted.
对单切口微型吊带(SIMS)用于治疗女性非神经源性压力性尿失禁的情况进行综述。
在Pubmed/MEdline数据库中检索至2013年6月的文献。因TVT-Secur™已不再上市,故将其排除。
Ajust™和Mini-Arc™是文献中评估的两种主要SIMS。关于Mini-Arc™的研究结果各异,1年后成功率在44%至91%之间。Ajust™是最具前景的器械,中期随访后有效率达80%。所有评估的SIMS即刻并发症发生率均较低。确定了两项比较SIMS与传统中段尿道吊带的随机对照试验以及一项荟萃分析;它们均得出微型吊带与传统吊带无优劣之分的结论。
由于随访时间短、证据有限且数据各异,SIMS尚未成为标准治疗方法,有必要进一步开展研究。